Cellebrite DI Ltd Financials

Market Capitalization ₪4.89 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	69.09
Forward PE	56.95
Price to Sales TTM	$12.71
Price to Book MRQ	$15.94
Enterprise to Revenue	11.41
Enterprise to EBITDA	65.45

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	-82.28%
Operating Margin	18.20%
Return on Assets TTM	6.35%
Return on Equity TTM	-188.50%

Income Statement

Revenue TTM	$385,167,008
Revenue per Share TTM	$1.93
Quarterly Revenue Growth	26.90%
Gross Profit TTM	$325,281,984
EBITDA	$67,167,000
Net Income to Common TTM	$-316,923,008
Diluted EPS TTM	$-1.58
Quarterly Earnings Growth YoY	26.94%

Balance Sheet

Total Cash MRQ	$370,763,008
Total Cash per Share MRQ	$1.78
Total Debt MRQ	$
Total Debt to Equity MRQ	4.11
Current Ratio MRQ	1.84
Book Value per Share MRQ	$1.43

Cash Flow

Operating Cash Flow TTM	$110,032,000
Levered Free Cash Flow TTM	$-72,342,248

CLBT Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	214,843,008
Float Shares	84,356,510
Avg 10 Volume	1,490,150
Avg 30 Volume	None
Shares Short	1,172,756
Short Ratio	1.11
Short % of Shares	1.05%
% Held by Insiders	46.79%
% Held by Institutions	53.11%

Stock Price Summary

Beta	1.50
Fifty Two Week Low	$8.91
Fifty Two Week High	$24.18
Fifty Two Week Change	60.00%
Day 50 MA	$20.55
Day 200 MA	$15.54

Dividends and Splits

Forward Annual Dividend Rate	$
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	$0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date